PTJ
AMPE

Paul Tudor Jones’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Paul Tudor Jones’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-287
Closed -$204K – 1807
2015
Q2 		$204K Buy
+287
New +$306K 0.01% 1330
2014
Q4 		– Sell
-376
Closed -$398K – 1642
2014
Q3 		$398K Buy
+376
New +$633K 0.01% 817

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CK
Carnick & Kubik Colorado Springs, Colorado $334M AUM 1.52% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Paul Tudor Jones's AMPE Position: Q3 2015 in Review

Paul Tudor Jones sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2015, closing a stake of 287 shares — an estimated $204K sold.

Paul Tudor Jones first reported a position in AMPE in Q3 2014 and held it in 2 quarters. The position peaked at $398K in Q3 2014. 51 funds tracked by Wall St. Rank hold AMPE as of Q3 2015.

  • Paul Tudor Jones reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2015 after selling out during the quarter.
  • Paul Tudor Jones sold 287 Ampio Pharmaceuticals Inc. shares in Q3 2015, an estimated $204K.
  • Paul Tudor Jones first reported a position in Ampio Pharmaceuticals Inc. in Q3 2014 and held it in 2 quarters.
  • Paul Tudor Jones's Ampio Pharmaceuticals Inc. position peaked at $398K in Q3 2014.
  • 51 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2015.

Based on Tudor Investment Corp's 13F filing for Q3 2015, filed 16 Nov 2015.